Last month, PM Farma, a well-recognized magazine in Spain about news in the pharmaceutical sector, interviewed Roldán Cortés, Director of Development and Marketing of MEDSIR at our office.
With more than 400,000 visits per month on its web portal, this platform serves as a communication vehicle between the different players within the healthcare arena, from the pharmaceutical industry to service companies, making it one of the main sources of information for this sector.
Our Director of Development and Marketing delivered an impeccable discourse on topics such as the differential value of our company compared to CROs and the benefits we provide to our stakeholders, whether they be medical oncologists or pharmaceutical and biotech companies. He also discussed our participation in SEOM (Spanish Society of Medical Oncology) where the results of the PARSIFAL (breast cancer) and EXCAAPE (prostate cancer) studies were presented. Furthermore, he touched on how the COVID-19 pandemic has affected our sector.
To view the video in Spanish, here is the link:
Here is the transcript of the entire interview.
